Tetrahexyldecyl Ascorbate for Cosmetic Buyers: Identity, Assay and Oil-Phase Fit

Tetrahexyldecyl ascorbate is often purchased as an oil-soluble vitamin C derivative. The difficult part is not finding a listing that says “stable,” “high purity” or “cosmetic grade.” It is establishing what the material actually is, how the reported assay was obtained, whether the lot has the expected physical behavior, and whether the supplier’s stability language applies to your package and formula. This guide treats THD ascorbate as a raw-material qualification problem, not as a consumer product recommendation.

The buying question is not simply “Is it oil-soluble?”

A sourcing team normally wants four answers before approving a new THD ascorbate source:

• Identity: Does the sample match the intended ester and CAS record, and are the names consistent across the quotation, label, specification and COA?
• Composition: Is the stated percentage an assay of the neat ester, a minimum release value, or the amount in a carrier or premix?
• Stability: What was tested, under what light, oxygen, temperature, package and time conditions?
• Formulation fit: Can the material be incorporated into the intended oil, emulsion or anhydrous system without changing the development target?

“Vitamin C derivative” is a functional description, not a complete material specification. A supplier may use THD ascorbate, tetrahexyldecyl ascorbate, ascorbyl tetraisopalmitate or ascorbyl tetra-2-hexyldecanoate in adjacent contexts. These names can point to the same commercial identity in some records, but a buyer should not resolve a nomenclature conflict by assumption. The CAS, structure, INCI name, assay method and lot documents must agree.

1. Lock the identity before comparing offers

For the common cosmetic raw-material identity discussed here, CAS 183476-82-6 is widely associated with tetrahexyldecyl ascorbate and ascorbyl tetraisopalmitate. Chemical catalogues and technical references also show why a name-only comparison is risky: the same CAS can be accompanied by different synonyms, while another CAS may appear in a supplier’s system for a related or alternative record. Record the exact name used by the supplier, the CAS they declare, the INCI name, and the molecular formula or structure where available.

2. What a useful THD ascorbate COA should show

There is no single public COA layout that proves every cosmetic raw material is equivalent. The practical standard is whether the document lets quality control connect the shipment to a defined specification and a defined lot. A one-line “assay 95%” result is not enough for that purpose.

• Lot number, manufacturing date, retest or expiry date, test date and issuing site.
• Identity method or reference standard. If the supplier uses FTIR, HPLC, NMR or another method, request the method name and acceptance criterion rather than only “conforms.”
• Assay method and basis. Clarify whether the result is HPLC area percent, a mass assay, a supplier-defined active content, or a result calculated against a reference standard.
• Physical description: colour, odour, state, clarity and any stated density or viscosity range. These are useful for incoming checks but do not replace chemical identity testing.
• Relevant oxidation or quality indicators. Depending on the grade, ask whether acid value, peroxide value, residual solvent, water, heavy metals or related substances are controlled.
• Storage and package: temperature, light protection, headspace or inert-gas statement, closure, and handling after opening.

The important distinction is between a specification and a batch result. “Assay ≥95%” is an acceptance limit. “Result 97.2%” is a lot-specific observation. The COA becomes decision-useful only when the lot number on the document matches the sample, quotation, drum label and shipment paperwork.

3. Do not convert “stable vitamin C” into a universal stability claim

THD ascorbate is often marketed as more stable than free ascorbic acid because esterification changes its solubility and reactivity profile. That comparison can be useful at a high level, but it does not mean the raw material is immune to degradation. A peer-reviewed study reported that tetrahexyldecyl ascorbate degraded rapidly under singlet-oxygen stress and that acetyl zingerone reduced that degradation in the tested system. The result is a direct reminder that the relevant question is not whether the ingredient is called stable; it is which stressors were applied and whether the tested system resembles the buyer’s formula.

For a new lot or supplier, ask for the actual stability design:

• Temperature and duration, including whether the result is real-time, accelerated or only a short screening observation.
• Light exposure or dark storage, oxygen exposure, headspace and package material.
• Test endpoint: assay retention, peroxide value, acid value, colour, odour, phase separation or another defined marker.
• Whether the result applies to neat raw material, a premix, an oil serum, an emulsion or a named finished product.
• Whether the same product code, manufacturing site and formulation used in the study are the ones being quoted.

A supplier’s stability statement can be recorded as supplier evidence, but it should not be rewritten as a general industry fact. Formula stability still needs to be demonstrated in the intended package and use conditions.

4. Oil-phase fit is a development variable, not just a catalogue feature

THD ascorbate is lipophilic, so first define the target format: anhydrous oil, silicone-rich serum, oil-in-water emulsion, water-in-oil emulsion or a premixed solution. The same raw material can behave differently as the solvent system, polarity, emulsifier package, temperature history and shear change.

• For an anhydrous oil, check clarity at room temperature and after the proposed low-temperature hold. Record haze, crystals, sediment or odour shift.
• For an emulsion, confirm the addition phase, pre-dilution solvent, mixing temperature and order of addition. Oil solubility alone does not predict emulsion stability.
• For a premix, document the actual THD ascorbate percentage and every carrier. A “20% solution” and a “95% neat material” are not comparable purchase units.
• For a transparent package, include light exposure in the stability plan. A dark or opaque package may change the result materially.
• For scale-up, repeat the check with production mixing and the final closure. Bench-top clarity is not proof of a stable commercial batch.

Write the formulation target as a measurable acceptance profile: appearance, assay or marker recovery, colour, odour, viscosity where relevant, phase behavior, package interaction and time points. This prevents a general compatibility statement from replacing actual development work.

5. How to compare THD ascorbate quotes

Price comparisons fail when one offer is neat material and another is a solution, when assay basis differs, or when package and logistics are hidden in the unit price. Normalize each candidate to the same basis before discussing “cheaper.”

A lower quote is not automatically a lower-cost source if the material requires extra pre-blending, has a lower active fraction, needs special storage, or fails incoming testing. The useful calculation is active-equivalent cost plus qualification and expected handling—not the headline price alone.

What the published evidence does—and does not—prove

The current literature supports a cautious positioning of THD ascorbate. It is a lipophilic derivative of ascorbic acid, and controlled studies have investigated antioxidant, pigmentation and photoaging-related outcomes. Those studies do not establish that every commercial lot has the same assay, impurity profile, oxidation resistance or skin performance. They also do not turn a raw-material specification into a finished-product efficacy claim.

The 2021 oxidative-stress study is especially useful for procurement because it challenges an easy marketing shortcut. The ingredient may be more convenient than free ascorbic acid in some oil-based designs, yet still be vulnerable to a particular oxidant environment. The paper tested a defined experimental system; it did not certify all suppliers, packages or finished formulas. Similarly, a 2024 topical study used a named serum containing THDA and acetyl zingerone. Its results cannot be assigned to a different raw material or to THDA alone unless the study design supports that attribution.

Use evidence at the correct level: chemical identity evidence for identity, analytical evidence for batch release, formulation evidence for physical stability, and controlled human or finished-product evidence for claims. Keeping those levels separate makes the RFQ and approval record easier to defend.

Current Sourcing Lead

The product sourcing link below is a sourcing lead, not a quality ranking. It was confirmed to land on the Product ID shown. Confirm the exact grade, active fraction, lot COA and package terms before ordering.

A product listing and a supplier storefront are different routes and are not interchangeable.

Incoming QC after the sample arrives

A COA review should be followed by a small, pre-defined receiving check. The purpose is not to recreate a full method-validation program at the warehouse. It is to detect obvious mismatch between the approved sample, the shipped lot and the intended processing behavior.

• Confirm the drum or bottle label, lot number and seal against the supplier paperwork before opening.
• Photograph and record the appearance, colour and odour under the same conditions used for the retained sample. Avoid treating a subjective colour impression as a purity result.
• Check whether the material is the expected liquid or viscous oil at the stated receiving temperature. If it is crystallized or hazy, record temperature and equilibration time before deciding that it is out of specification.
• Run the agreed identity or assay screen when the material is critical to the formula. A supplier COA is release evidence from the supplier; it is not the same as independent confirmation.
• Prepare a small formula screen using the approved solvent and addition sequence. Record clarity, separation, colour, odour and any change after the planned heat, light and freeze-thaw exposures.
• Retain a sealed reference sample and the current specification so a later supplier lot can be compared against the approved material.

This receiving sequence is particularly important when the quotation uses broad language such as “oil-soluble vitamin C.” The phrase may describe a real ingredient, but it does not identify the exact grade, carrier, deodorization state or release method. Those details belong in the approved material record.

A practical RFQ checklist

Send these questions before requesting a final production quote:

• Confirm the exact chemical identity, CAS, INCI name and all synonyms used for the quoted grade.
• Is the material neat THD ascorbate or a solution / blend? State the active percentage on a defined basis.
• Provide the current specification and a batch-specific COA for a representative lot, including assay method and result.
• State the lot number, manufacturing site, production date, retest or expiry date, storage temperature and package configuration.
• Which stability data were generated on this grade, and what were the temperature, light, oxygen, package and endpoints?
• Can the same product code and specification be maintained for repeat orders, with advance notice of site, method or package changes?
• Provide a sample for a matched formula screen before commercial approval.

Bottom line

THD ascorbate can be a commercially useful oil-soluble vitamin C derivative, but “stable,” “cosmetic grade” and “95% purity” are starting points rather than qualification conclusions. A defensible decision rests on a consistent identity record, an interpretable assay, lot traceability, condition-specific stability evidence and a formulation test in the intended oil or emulsion. The sourcing lead below is an entry point for that evaluation, not a quality endorsement: it was confirmed to land on the product ID shown, and everything else about the offer still has to be verified against the lot documents.

References

1.Swindell WR et al. Tetrahexyldecyl Ascorbate (THDC) Degrades Rapidly under Oxidative Stress but Can Be Stabilized by Acetyl Zingerone. Antioxidants. 2021. https://pubmed.ncbi.nlm.nih.gov/34445461/

2.Min M et al. Open-label topical application of tetrahexyldecyl ascorbate and acetyl zingerone. Journal of Cosmetic Dermatology. 2024. https://pubmed.ncbi.nlm.nih.gov/38634176/

3.Afzal N et al. Prospective randomized double-blind comparative study of topical acetyl zingerone with tetrahexyldecyl ascorbate versus tetrahexyldecyl ascorbate. 2024. https://pubmed.ncbi.nlm.nih.gov/38525606/

4.CAS Common Chemistry. Cosmetic raw-material identity records. https://commonchemistry.cas.org/

5.European Commission. CosIng cosmetic ingredient database. https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database_en